Skip to content
EntityQ27285470· pop 9· linked from 168 articles

Also known as Tavneos

Avacopan, sold under the brand name Tavneos, is a medication used to treat anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Avacopan is a complement 5a receptor antagonist and a cytochrome P450 3A4 inhibitor.

~7 min read

Encyclopedic overview

8 sections
Contents
  • Medical uses
  • History
  • Society and culture
  • Legal status
  • Names
  • References
  • Further reading
  • External links

{{Infobox drug | image = Avacopan structure.svg | image_class = skin-invert-image | width = 250px | alt = | caption =

| pronounce = | tradename = Tavneos | Drugs.com = | MedlinePlus = a622023 | DailyMedID = Avacopan | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = By mouth | class = Complement C5a receptor antagonist | ATC_prefix = L04 | ATC_suffix = AJ05 | ATC_supplemental =

Excerpted from Wikipedia’s “avacopan” article, available under the CC BY-SA 4.0 licence.

Available in 10 languages

via Wikidata sitelinks · CC0